Optimizing Empiric Vancomycin Use in Febrile Neutropenia Patients
نویسندگان
چکیده
Introduction: National guidelines do not support routine empiric vancomycin use in the initial management of febrile neutropenia (FN) and only recommend it patients with specific clinical indications. This bi-phasic quality improvement project aimed to evaluate current FN improve compliance a guideline-driven algorithm (GDA) ensure appropriate prescribing therapy duration community hospital.
منابع مشابه
Empiric Vancomycin Use in Febrile Neutropenic Oncology Patients
Vancomycin is commonly added as empiric therapy for febrile neutropenia. A retrospective chart review was conducted at a large community teaching institution to evaluate vancomycin use in oncology patients. The results revealed that a majority of empiric vancomycin therapy was inappropriate, raising concern for antibiotic resistance and prompting opportunities for improvement.
متن کاملAn observational study on the empiric use of cefpirome in febrile neutropenia.
BACKGROUND AND PURPOSE The objective of this study was to document the clinical experience of cefpirome use in the treatment of febrile neutropenia in everyday medical practice. METHODS This was an open, non-controlled multicenter study. Patients with fever and neutropenia were started on cefpirome empirically. Response to therapy was evaluated 72 to 96 h after the beginning of treatment. The...
متن کاملConsensus on diagnosis and empiric antibiotic therapy of febrile neutropenia
Controversial issues on the management of empiric therapy and diagnosis of febrile neutropenia (FN) were faced by a Consensus Group of the Italian Association of Pediatric Hematology-Oncology (AIEOP). In this paper we report the suggestions of the consensus process regarding the role of aminoglycosides, glycopeptides and oral antibiotics in empiric therapy of FN, the rules for changing or disco...
متن کاملEarly Empiric Antibiotic Therapy for Febrile Neutropenia Patients at Low Risk.
Although it is apparent that certain patients with febrile neutropenic episodes can benefit from outpatient antibiotic therapy, not all low-risk patients are treated in this fashion. There are barriers, real and perceived, to implementing this approach for patients, health care providers, and caregivers. Table 3 summarizes the advantages and disadvantages of ambulatory management of febrile neu...
متن کاملInstitutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
STUDY OBJECTIVE To assess the effectiveness, safety, and cost of empiric treatment of febrile neutropenia before and after implementing an algorithm in which voriconazole was substituted for liposomal amphotericin B (L-AmB). DESIGN Retrospective cohort analysis. SETTING An 850-bed tertiary care hospital, which is also a referral site for patients with acute leukemia. PATIENTS Fifty-five a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nursing & health sciences research journal
سال: 2021
ISSN: ['2578-3750']
DOI: https://doi.org/10.55481/2578-3750.1101